BHI
logo
  • Health Plans
    • Transparency Analytics
    • Plan Performance Analytics
    • Provider Analytics
    • Employer Analytics
    • Health Equity
    • Risk Adjustment
  • Real-World Evidence Generation
  • Resources
  • About
    • Company
    • Leadership
  • Careers
  • Contact Us
  • Subscribe

JUST RELEASED

Real-World Trends in GLP-1 Prescribing and Treatment Persistence for Weight Management

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Read the Issue Brief

Sign up to receive updates from BHI

Subscribe
Hide filtersShow filters
× Close
  • Benchmarking
  • Boost Your Skills
  • COVID-19
  • Chronic disease management
  • Episode of Care Grouper
  • HITRUST
  • National Benchmarking
  • Physician performance
  • Population Advyzer
  • Predictive analytics
  • Prescription drugs
  • Price transparency
  • QE
  • REL data
  • Real-world data (RWD)
  • Risk Adjustment
  • Risk scoring
  • Transparency Analytics
  • artificial intelligence
  • behavioral health
  • cost transparency
  • employer analytics and reporting
  • health equity
  • hospital outpatient care
  • machine learning
  • medical device
  • real-world evidence (RWE)
  • site-neutral
  • telehealth
  • value-based care
  • whyzen analytics

Clear all Apply

Webinars

What’s Driving Cancer Costs, How to Compare Populations with Chronic Conditions

Blog

Price Transparency: Unlock the Power of MRFs

Reports

BHI’s Qualified Entity Report Confirms Health Inequities Drive Diabetes-Related Admissions

Webinars

Auto-sync, Variance Table Extensions, and New Dashboards

News

Blue Health Intelligence Names Sam Mohanty as Chief Technology Officer

News

Blue Health Intelligence Names Matt Siegel as Chief Growth Officer

Blog

The New Era of Healthcare Cost Transparency: What’s Ahead

News

Blue Health Intelligence Names Chris Birkmeyer to Lead Product Strategy

Webinars

Rank Measures in a Table, Create Custom Dashboards, and Build Statistical Charts

  • 1
  • 2
  • 3
  • 4
  • …
  • 7

© 2024 Blue Health Intelligence. Blue Health Intelligence (BHI) is a trade name of Health Intelligence Company LLC, an independent licensee of the Blue Cross Blue Shield Association.

Privacy Preference Center

Privacy Preferences